Studies Currently Recruiting

People walking together down the sidewalk

Frailty Prevention

The overall goal of this project is to determine whether metformin treatment prevents or reduces frailty in older adults who have pre-diabetes.



The purpose of the South Texas Aging Registry and Repository (STARR) is to collect health information, blood and specimens to store for future research purposes. We want to learn more about how to improve the health and quality of life of older adults. We are also working to learn how genes affect the way a person ages or how aging influences genes and the cells they affect.

People Excersizing on a teadmill

Exercise Science/MoTrPAC

You know that exercise is good for your health, but have you ever wondered why? We’re looking for men and women who are 18 years of age and older to participate in our MoTrPAC research study.


This study will evaluate the combination of two medications to see if it has effects on individuals with early Alzheimer’s disease.


Looking for participants who are 60 and older, overweight, and have borderline diabetes. We want to evaluate the effect of the FDA approved medication dapagliflozin on the reduction of cellular damage, pro-inflammatory cells of aging and other known markers of biological aging.


The purpose of this study is to learn if taking a statin could help older adults live well for longer by preventing dementia, disability or heart disease.


This study will evaluate if the medication 3TC will effectively prevent decline and loss of function in the nervous system of adults with early Alzheimer’s Disease.

Over-eating & Older Women

The purpose of this research study is to understand how experiences related to aging impact over-eating behaviors in women.

Topical RAPA

Help us find out if using RAPA ointment can slow down the aging of skin cells.

REACH Clinical Trial

This trial will evaluate the use of Rapamycin to slow progression of amnestic mild cognitive impairment and early-stage Alzheimer’s.


The purpose of this study is to evaluate if if the drug, Rapamycin, will reach the brain and effectively treat symptoms of Alzheimer’s disease and mild cognitive impairment using cerebrospinal fluid.